MedTrace Logo

Acceptance and Feasibility of Hepatitis c Screening Strategies in Social Insertion Centers

NCT05756738 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 854

Last updated 2023-12-05

No results posted yet for this study

Summary

Hepatitis C virus (HCV) infection is one of the leading causes of chronic liver disease worldwide. It is a progressive disease that without treatment leads to the development of cirrhosis in approximately 10-20% of patients. With this study the investigators intend to evaluate the efficacy defined as the rate of HCV diagnostic tests performed within a decentralized diagnostic strategy by means of home self-testing compared to the one performed in situ in the population served in Social Insertion Centers (CIS) with alternative prison sentences, in order to study the prevalence and characteristics associated with HCV infection in this population, which is known to be at risk for this disease, and to offer them treatment and cure.

Conditions

  • Hepatitis C Virus

Interventions

DIAGNOSTIC_TEST

Dried blood spot testing

To evaluate the efficacy defined as the rate of diagnostic tests against hepatitis C virus (HCV) performed with a dried blood spot test

Sponsors & Collaborators

  • University of La Laguna

    lead OTHER

Principal Investigators

  • Hernández Guerra · University of La Laguna

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-10
Primary Completion
2024-01-10
Completion
2024-01-10

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756738 on ClinicalTrials.gov